
Accenture plc (NYSE: ACN) clears all three hard screening criteria definitively — ROE of 26.72%/26.77%/24.29% in FY2023–FY2025 (SEC EDGAR XBRL verified), free cash flow accelerating to $12.5B TTM, and a trailing P/E of 14.30× that is 51% below its 5-year historical average and at the peer-group median. The central tension is a genuine bull/bear split on AI disruption: the market has re-rated the entire IT services sector lower on fears that AI will cannibalize Accenture’s consulting and BPO revenue, but the company’s own GenAI bookings are running at $2.2B per quarter (+76% year-over-year) and the balance sheet is an AA−-rated fortress with net cash and 43× interest coverage. Q3 FY2026 earnings on June 18, 2026 are the next material data point.
| Fiscal year | Net income (SEC) | Shareholders' equity (year-end) | SEC-computed ROE | StockAnalysis ROE | Discrepancy |
|---|---|---|---|---|---|
| FY2021 (ended Aug 2021) | — | — | — | 31.87% ✓ | — |
| FY2022 (ended Aug 2022) | — | — | — | 32.63% ✓ | — |
| FY2023 (ended Aug 2023) | $5,907M | $22,106M | 26.72% ✓ | 28.47% | +1.75pp |
| FY2024 (ended Aug 2024) | $6,877M | $25,693M | 26.77% ✓ | 26.67% | −0.10pp |
| FY2025 (ended Aug 2025) | $6,872M | $28,289M | 24.29% ✓ | 25.51% | +1.22pp |
| TTM (ended Feb 28, 2026) | $7,648M | — | — | 24.10% ✓ | — |
us-gaap:NetIncomeLoss (attributable to parent) divided by year-end us-gaap:StockholdersEquity from Accenture's 10-K filings (CIK 0001467373). 6 StockAnalysis uses average shareholders' equity, which produces a modestly higher result in years when equity is growing. Both methods confirm every year clears 15% by a wide margin. The directional trend — declining from the FY2021–FY2022 peak of 31–33% to the current 24% range — is consistent across both sources. All three hard-criteria years (FY2023–FY2025) are confirmed against SEC filings with discrepancies of ≤1.75 percentage points. 56| Period | OCF | CapEx | FCF | FCF margin | YoY change |
|---|---|---|---|---|---|
| FY2023 | $9,524M | $528M | $8,996M | 14.0% | — |
| FY2024 | $9,131M | $517M | $8,614M | 13.3% | −4.2% |
| FY2025 | $11,474M | $600M | $10,874M | 15.6% | +26.2% |
| TTM (Feb 28, 2026) | $13,080M | $583M | $12,497M | 17.3% | — |
| Multiple | Current | FY2021–FY2025 average | Discount to history |
|---|---|---|---|
| Trailing P/E | 14.30× | 29.00× | −50.7% |
| P/B | 3.44× | 7.96× | −56.8% |
| EV/EBITDA | 8.33× | 17.14× | −51.4% |
| Company | Trailing P/E | Forward P/E | P/B | EV/EBITDA | One-line description |
|---|---|---|---|---|---|
| ACN (Accenture) | 14.30× | 12.22× | 3.44× | 8.33× | Global #1 IT services; AI-exposed consulting |
| IBM (Int'l Business Machines) | 24.88× | 22.36× | 8.00× | 19.38× | Hybrid cloud/AI + enterprise services |
| CTSH (Cognizant) | 11.52× | 9.14× | 1.67× | 6.34× | IT services/outsourcing; closest ACN comp |
| INFY (Infosys) | 15.09× | 15.28× | 5.08× | 10.70× | Global IT consulting; India-based |
| EPAM (EPAM Systems) | 13.86× | 7.24× | 1.49× | 5.88× | Custom software development |
| Peer median | 14.48× | 12.21× | 3.38× | 8.52× | — |
| ACN vs. median | −1.2% | +0.1% | +1.8% | −2.2% | — |
| Period | Revenue | YoY growth | Net income | Operating margin | Net margin |
|---|---|---|---|---|---|
| FY2021 | $50,533M | — | $5,907M | 15.1% | 11.9% |
| FY2022 | $61,594M | +21.9% | $6,877M | 15.2% | 11.4% |
| FY2023 | $64,112M | +4.1% | $6,872M | 13.7% (trough) | 10.9% |
| FY2024 | $64,897M | +1.2% | $7,265M | 14.8% | 11.4% |
| FY2025 | $69,673M | +7.4% | $7,678M | 14.7% | 11.2% |
| TTM | $72,110M | +7.3% | $7,648M | 14.4% | 10.8% |
| Metric | Value | Context |
|---|---|---|
| Total cash | $9,410M | — |
| Total debt | $8,350M | — |
| Net cash position | $1,060M ($1.72/share) | Net cash — rare for a $107B company |
| Debt / equity | 0.25× | Versus IBM's 2.11× |
| Interest coverage (EBIT/interest) | 43.14× | EBIT $11.34B; interest ~$263M |
| Current ratio | 1.34× | Healthy; cash > near-term obligations |
| ROIC | 27.19% | Well above estimated WACC of ~9.6% |
| Maturity | Amount | Coupon |
|---|---|---|
| FY2026 remainder | $100M | Commercial paper (4.1% avg rate) |
| FY2028 | $1,100M | 3.90% senior notes |
| FY2030 | $1,200M | 4.05% senior notes |
| FY2032+ | $2,700M | 4.25%–4.50% senior notes |
| Total | $5,100M | Fixed rate; no financial covenants |
stockanalysis.com
useluminix.com
sitsi.pacanalyst.com
newsroom.accenture.com
stockanalysis.com
stockanalysis.com
macrotrends.net
macrotrends.net
stockanalysis.com
stockanalysis.com
stockanalysis.com
stockanalysis.com
investor.accenture.com
finviz.com
bobhammel.substack.com
newsroom.accenture.com
stockanalysis.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.
| Stock price | $174.43 |
| Trailing P/E | 14.30× |
| Forward P/E | 12.22× |
| PEG | 1.73 |
| P/B | 3.44× |
| EV/EBITDA | 8.33× |
| P/FCF | 8.57× |
| FCF yield (TTM) | 11.67% |
| Dividend yield | 3.74% |
| 52-week range | $155.82 – $321.77 |